Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dofetilide versus quinidine for atrial flutter: viva la difference!?

B Olshansky

    Journal of Cardiovascular Electrophysiology
    |September 1, 1996
    PubMed
    Summary

    Dofetilide effectively terminates atrial flutter and uniformly lengthens refractoriness in an animal model, outperforming quinidine. Further research is needed to confirm its efficacy and safety in human atrial arrhythmias.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    'Transient immediate orthostatic hypotension' is preferable to 'initial' orthostatic hypotension.

    Autonomic neuroscience : basic & clinical·2025
    Same author

    Tachycardia-induced ventricular dysfunction jigsaw: do all pieces now fit?

    Acta physiologica (Oxford, England)·2016
    Same author

    Sports participation in patients with implantable cardioverter-defibrillators.

    Herzschrittmachertherapie & Elektrophysiologie·2012
    Same author

    Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness.

    International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2008
    Same author

    Thorough QT study with recommended and supratherapeutic doses of tolterodine.

    Clinical pharmacology and therapeutics·2007
    Same author

    Case 5: atrial fibrillation after coronary artery bypass grafting.

    The American journal of cardiology·2002

    Area of Science:

    • Cardiology
    • Pharmacology
    • Electrophysiology

    Background:

    • Atrial flutter is a common arrhythmia requiring effective treatment.
    • Quinidine, a Class IA antiarrhythmic, has been used but carries risks.
    • Dofetilide, a Class III antiarrhythmic, offers a potential alternative for atrial arrhythmias.

    Purpose of the Study:

    • To compare the efficacy of dofetilide and quinidine in terminating atrial flutter.
    • To investigate the electrophysiologic mechanisms underlying the antiarrhythmic effects of dofetilide and quinidine.
    • To assess the impact of these drugs on refractoriness and reentrant circuits in an animal model.

    Main Methods:

    • Utilized an animal model to study atrial flutter termination.
    • Meticulously analyzed local refractoriness, dispersion of refractoriness, and wavelength.
    • Compared the electrophysiologic effects of dofetilide and quinidine.

    Main Results:

    • Dofetilide demonstrated superior efficacy in terminating atrial flutter compared to quinidine.
    • Dofetilide exhibited more uniform lengthening of atrial refractoriness than quinidine.
    • The precise mechanisms by which these drugs affect flutter termination and reinduction require further elucidation.

    Conclusions:

    • Dofetilide shows promise as a more effective and potentially safer antiarrhythmic agent for atrial flutter than quinidine in this model.
    • Additional studies are essential to validate these findings in human subjects and assess dofetilide's safety profile, particularly regarding torsades de pointes.
    • The development of safer and more potent antiarrhythmic compounds is crucial, potentially guiding future therapeutic strategies alongside interventions like radiofrequency ablation.

    Related Experiment Videos